Brief: Healios and Athersys enter into regenerative medicine partnership for treatment of stroke using multistem therapy
08/01/2016 08:00
Jan 8 (Reuters) - Athersys Inc ATHX.O : * Healios and Athersys enter into regenerative medicine partnership for treatment of stroke using multistem therapy * Under the terms of the agreement, Healios will gain exclusive rights for the development of multistem for treating ischemic stroke in Japan * In addition, Healios will obtain an exclusive option for development of two additional multistem clinical indications in Japan * Says Healios will also obtain an exclusive license to incorporate Athersys Technology * Says as part of the license, Athersys will receive an initial license fee of $15 million * Source text for Eikon ID:nGNXMJBLQa * Further company coverage ATHX.O ((Bengaluru Newsroom; +1 646 223 8780))